Featured Articles

  1. Solid Tumors: The Next Frontier Of Cancer Immunotherapy 2/14/2024

    With the use of advanced in vitro models like Organ-Chips, researchers are gaining a better understanding of CAR T-cell therapy in the context of solid tumors.

  2. An Introduction To Gene Therapy And Its Drug Development Applications 2/14/2024

    Gain an understanding of gene therapy, including its history, advantages, disadvantages, and in vivo and ex vivo processes, and how Organ-Chips can be utilized to advance gene therapy development.

  3. Tackling The Drug Development Crisis Using Improved Preclinical Models 2/13/2024

    The productivity of drug development has sharply declined over the past seven decades. Discover how improving preclinical models holds the key to solving the challenge at the heart of drug development.

  4. What Are Organ-Chips? 2/13/2024

    Learn in detail about Organ-on-a-Chip technology and how it is paving the way for the next generation of drug development and research.

  5. Are Non-Human Primates A Research Dead End? 2/13/2024

    The time has come to move away from using non-human primates as test subjects in biomedical research and embrace more practical, reproducible, and cost-effective models.

  6. Predictive Validity: The Key To Improving The Drug Development Process 2/13/2024

    The drug development industry recognizes the importance of predictive validity, but Jack Scannell, the author of Eroom’s law, and a team of experts argue it is far more crucial than most believe it is.

  7. Boost Drug Development Productivity With Contract Research Services 2/13/2024

    Find out how organ-on-a-chip contract research services are enabling the pharmaceutical industry to overcome the largest challenge in drug development—Eroom’s Law.

  8. Organ-Chips And Organoids: Better Together 2/13/2024

    Combining organoids with Organ-Chips enables the development of more accurate human biological models. Learn how these technologies are opening the door for new experimental approaches and more.

  9. Charting Our Path Forward: Determination And Resilience Attracts $82M Series E Funding 9/7/2021

    Emulate CEO Jim Corbett explains how new funding will allow the company to significantly expand its research and development efforts.

  10. Congressional Briefing Highlights The Importance Of Alternatives To Animal Models 3/23/2021

    Continue reading to learn more about the virtual briefing titled “21st Century Alternatives to Animals in Biomedical Research” as well as more human-relevant testing solutions that have been developed since.